CLL
Conference Coverage
MHM: Novel agents, combos show promise for relapsed/refractory CLL
Novel agents and combinations are showing great promise in relapsed/refractory CLL.
Conference Coverage
CLL Therapy: Focus on comorbidities, not age
The majority of patients with chronic lymphocytic leukemia are elderly patients over age 65 years, which underscores the need for a careful...
Conference Coverage
CLL: No symptoms, no treatment still appropriate
Despite exciting new advances in the understanding of chronic lymphocytic leukemia, particularly with respect to prognostic features that predict...
News
HELIOS trial: Ibrutinib safely boosts survival in CLL/SLL
Adding ibrutinib to bendamustine and rituximab improved outcomes without significantly reducing safety in patients with chronic lymphocytic...
News
No evidence for CLL transmission via blood transfusion
Key clinical point: There is no evidence for higher risk of chronic lymphocytic leukemia (CLL) among recipients of blood products from donors who...
News
CLL exosomes promote stromal cell transition into cancer-associated fibroblasts
Key clinical point: Exosomes derived from chronic lymphocytic leukemia (CLL) cells induce stromal cell transition to cancer-associated fibroblasts...
News
Reovirus ready for clinical testing in CLL
Key clinical point: Reovirus, a naturally occurring oncolytic virus, in combination with anti-CD20 immunotherapy, may have benefit for the...
News
CLL patients achieve remission with CAR-modified T-cells
Key clinical point: CAR-modified T cell therapy lacks the toxicities and limitations of allogeneic stem cell transplantation and may be an...
News
Melanoma twice as likely after CLL/SLL than other types of NHL
Key clinical point: Survivors of chronic lymphocytic leukemia/small lymphocytic lymphoma are twice as likely to develop melanoma as are survivors...
Conference Coverage
Index discriminates prognostic groups in CLL
Key clinical point: An international prognostic index for patients with chronic lymphocytic leukemia may help to inform treatment decisions. Major...